This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Other/unspecified site
CD2_BENIGN_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Other/unspecified site
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Other/unspecified site
- Benign neoplasm of other and unspecified sites
- Benign neoplasm of other and unspecified sites
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 564 | 330 | 234 |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | 0.10 |
| Median age at first event (years) | 49.90 | 46.84 | 54.22 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 513
- Matched controls
- 5129
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
+∞
323.0
345
*
22899
ICD-8 Finland
Benign neoplasm of other and unspecified organs and tissues
+∞
110.5
102
*
D36.9
ICD-10 Finland
Benign neoplasm: Benign neoplasm of unspecified site
+∞
60.6
57
*
130
Kela drug reimbursment
Malignant tumour
+∞
42.3
40
*
DHB10
NOMESCO Finland
Excision of lesion of internal nose
124.9
33.1
35
*
115
Kela drug reimbursment
Breast cancer
+∞
29.5
28
*
H02AB02
ATC
dexamethasone; systemic
36.1
29.1
37
11
DHB00
NOMESCO Finland
Excision of lesion of external nose
79.6
27.1
30
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
102.3
26.9
29
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.2
26.9
62
85
A04AA02
ATC
granisetron; systemic, transdermal
+∞
26.3
25
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.2
24
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
23.1
22
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
87.5
22.9
25
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
22.0
21
*
PJA12
NOMESCO Finland
Sentinel node biopsy
229.3
21.8
22
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
25.5
21.1
29
12
DHA10
NOMESCO Finland
Biopsy of cavity of nose
21.0
17.9
26
13
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
16.8
16
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
164.8
15.6
16
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.1
14.8
33
43
116
Kela drug reimbursment
Prostate cancer
+∞
14.6
14
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
JN4BD
NOMESCO Finland
Extensive body CT
4.8
14.6
49
110
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
9.0
13.9
29
34
WF002
NOMESCO Finland
Radical radiotherapy
54.9
13.9
16
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.2
13.8
54
141
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
13.6
13
*
L01BC06
ATC
capecitabine; oral
+∞
13.6
13
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.6
13
*
L02BA01
ATC
tamoxifen; oral
71.7
12.6
14
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
12.5
12
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
12.5
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
11.8
86
357
HAC20
NOMESCO Finland
Total mastectomy
66.5
11.7
13
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
11.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
11.5
11
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
11.5
11
*
L02BG04
ATC
letrozole; oral
10.4
11.1
21
21
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.1
11.0
42
108
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
10.9
10.9
20
19
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
10.8
141
779
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
61.3
10.7
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
10.6
130
698
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
10.6
102
490
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
112.2
10.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.0
10.4
28
49
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
16.5
10.4
16
10
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
10.3
47
141
A04AA01
ATC
ondansetron; systemic, rectal
6.9
10.3
25
38
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
56.1
9.7
11
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.6
9.5
32
73
Y77
ICPC
Malignant neoplasm prostate
101.8
9.4
10
*
2899X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Unspecified diseases of blood and blood-forming organs
+∞
9.4
9
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
9.4
9
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
9.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
JN4AD
NOMESCO Finland
Body CT examination
4.8
9.4
30
65
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
9.0
201
1338
XX3DW
NOMESCO Finland
Time consuming IT work
3.7
9.0
38
108
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.6
8.6
37
107
UJF32
NOMESCO Finland
Coloscopy
2.0
8.5
129
746
N02BE01
ATC
paracetamol; systemic, rectal
2.0
8.4
426
3657
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
B01AB05
ATC
enoxaparin; parenteral
1.9
8.2
138
830
A02BC02
ATC
pantoprazole; systemic
1.7
8.2
313
2437
ZZR00
NOMESCO Finland
Flap of skin
22.4
8.0
11
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
7.8
179
1190
J02AC01
ATC
fluconazole; systemic
1.7
7.8
196
1344
WZC30
NOMESCO Finland
Teaching
2.6
7.6
53
214
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
18.7
7.6
11
6
WX110
NOMESCO Finland
Local anesthesy
1.7
7.5
324
2584
P01AB01
ATC
metronidazole; oral, rectal
1.7
7.5
196
1354
ZXA00
NOMESCO Finland
Right side
1.8
7.4
138
856
ZX090
NOMESCO Finland
Other technic of radiotherapy
81.2
7.4
8
*
HA1AA
NOMESCO Finland
X-ray mammography
4.9
7.4
23
49
A02BC05
ATC
esomeprazole; systemic
1.7
7.4
200
1397
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
DJW00
NOMESCO Finland
Removal of local lesion of nasal septum
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
N02AA05
ATC
oxycodone; systemic
2.5
7.3
59
258
ZXA05
NOMESCO Finland
Left side
1.9
7.2
130
795
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.1
7.2
37
124
NK6AN
NOMESCO Finland
Total body bone isotope imaging
30.5
7.2
9
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.8
7.1
19
34
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
10.2
7.1
13
13
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
7.0
30
87
J31.0
ICD-10 Finland
Chronic rhinitis
2.7
7.0
48
192
J01AA02
ATC
doxycycline; systemic
1.7
6.9
386
3271
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.2
6.9
20
40
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
6.8
43
162
Z51.5
ICD-10 Finland
Palliative care
5.8
6.8
18
32
S18
ICPC
Laceration/cut
1.7
6.8
201
1430
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
6.7
46
184
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.6
137
874
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
10.2
6.6
12
12
A02BC03
ATC
lansoprazole; oral
1.7
6.5
150
990
JN4CD
NOMESCO Finland
Very extensive body CT
6.7
6.4
15
23
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
6.3
53
236
X76
ICPC
Malignant neoplasm breast female
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
R01AD08
ATC
fluticasone; nasal
1.7
6.1
141
929
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
71
213
3.67
20.43
3.2
1.5
106.8
4.2
ug/l
0.50
63
159
37
86
4.53
14.98
2.8
1.8
62.9
145.0
u/ml
0.40
29
69
300
2086
1.94
13.19
7.2
3.7
10.8
11.6
umol/l
0.54
283
1974
76
313
2.65
12.58
2.1
2.0
0.2
0.2
g/l
0.78
71
281
292
2043
1.89
12.29
6.5
5.4
1.2
1.2
mmol/l
0.05
255
1759
269
1842
1.88
12.03
4.9
3.5
—
—
—
0
0
415
3272
2.02
12.01
9.0
5.3
78.1
75.4
u/l
0.53
390
3034
255
1738
1.85
11.39
5.2
3.6
35.5
35.9
g/l
0.63
229
1602
320
2369
1.81
10.65
10.0
6.3
4.0
4.2
e9/l
0.75
296
2087
62
262
2.54
9.70
1.7
1.5
—
—
—
0
0
259
1839
1.76
9.60
6.8
4.9
1.2
1.2
mmol/l
0.57
238
1650
329
2530
1.72
8.91
5.7
4.0
6.6
6.7
mmol/l
1.01
311
2352
79
397
2.15
8.30
3.0
1.7
354.2
364.4
nmol/l
0.19
73
366
198
1359
1.70
7.92
3.8
2.0
2.4
2.4
mmol/l
0.22
168
1147
198
1360
1.70
7.89
3.0
2.2
59.4
56.9
u/l
0.30
182
1253
212
1500
1.66
7.47
3.5
2.9
—
—
—
0
0
143
912
1.76
7.36
2.4
2.0
—
—
—
0
0
21
55
3.93
7.31
1.2
1.2
—
—
—
0
0
402
3370
1.67
6.94
4.7
4.1
11.1
11.5
mm/h
0.31
372
3118
79
426
1.99
6.85
2.9
2.2
11.4
7.7
umol/l
0.44
66
366
81
446
1.95
6.61
6.6
6.2
1.6
1.5
mmol/l
0.07
64
351
96
565
1.84
6.40
3.1
2.8
0.8
0.8
mmol/l
0.72
90
521
192
1379
1.59
6.12
4.0
2.8
30.9
31.7
u/l
0.16
177
1313
81
459
1.89
6.06
8.8
5.4
104.5
104.1
mmol/l
0.31
81
446
497
4532
1.81
5.03
18.6
11.8
21.9
22.6
mg/l
0.20
412
3465
104
672
1.67
4.96
2.1
1.7
—
—
—
0
0
137
949
1.59
4.95
1.7
1.7
1.3
1.0
mg/l
0.65
101
738
9
10
9.12
4.80
2.4
1.0
—
—
—
0
0
9
10
9.12
4.80
2.4
1.0
—
—
—
0
0
13
33
4.01
4.73
1.3
1.2
—
—
—
0
0
13
33
4.01
4.73
1.3
1.2
—
—
—
0
0
13
33
4.01
4.73
1.3
1.2
—
—
—
0
0
220
1705
1.48
4.67
4.4
3.6
29.8
58.1
ng/l
0.71
154
1181
149
1068
1.54
4.59
2.4
2.2
3.2
3.0
mg/l
0.34
120
912
159
1156
1.52
4.59
3.0
2.8
0.6
0.4
e6/l
0.12
128
865
26
106
2.52
4.44
1.4
1.3
268.3
326.0
ug/g
0.89
19
67
46
242
1.98
4.30
4.1
3.1
4.4
4.6
pmol/l
0.69
41
210
99
659
1.61
4.18
2.1
2.2
12.7
13.7
umol/l
0.68
89
609
83
535
1.65
3.98
2.1
2.3
23.4
23.8
%
0.07
66
457
229
1836
1.42
3.88
2.2
2.3
80.5
77.7
nmol/l
0.65
201
1639
8
11
7.36
3.87
1.0
1.5
—
—
—
0
0
8
11
7.36
3.87
1.0
1.4
—
—
—
0
0
8
11
7.36
3.87
1.0
1.4
—
—
—
0
0
504
4689
1.70
3.76
21.1
14.0
139.8
139.8
mmol/l
0.01
490
4558
463
4225
1.54
3.72
5.7
4.7
1.8
2.2
mu/l
0.70
426
3874
9
16
5.70
3.67
1.1
1.6
—
—
—
0
0
56
332
1.76
3.65
3.1
3.8
91.1
87.8
ng/l
0.08
44
297
504
4700
1.68
3.59
21.0
14.1
4.0
4.0
mmol/l
0.10
486
4564
87
588
1.57
3.44
2.2
2.2
2.3
2.3
g/l
0.09
78
551
419
3770
1.43
3.42
20.7
14.1
13.7
13.6
%
0.74
410
3682
32
162
2.03
3.36
1.7
1.6
—
—
—
0
0
180
1414
1.40
3.33
2.3
2.2
347.2
243.6
u/l
0.37
169
1325
394
3518
1.40
3.27
5.1
3.9
15.1
14.8
pmol/l
1.38
364
3219
20
85
2.40
3.18
1.3
1.6
—
—
—
0
0
78
524
1.57
3.17
5.1
4.6
1.0
1.0
mmol/l
0.02
73
477
158
1226
1.40
3.11
1.7
1.7
1.4
1.4
mmol/l
0.14
133
1031
150
1154
1.41
3.10
5.1
3.7
0.0
0.0
estimate
0.50
51
356
57
357
1.66
3.07
2.1
2.1
68.4
66.9
ml/min/173m2
0.08
22
149
26
126
2.11
3.07
1.9
1.7
283.3
285.2
mu/l
0.01
21
115
11
35
3.19
2.94
1.3
1.5
—
—
—
0
0
19
82
2.36
2.94
1.4
1.6
—
—
—
0
0
107
781
1.46
2.94
2.8
2.1
2.5
2.4
mmol/l
2.81
91
674
8
17
4.76
2.93
1.0
1.4
—
—
—
0
0
8
17
4.76
2.93
1.0
1.4
—
—
—
0
0
8
17
4.76
2.93
2.4
2.2
—
—
—
0
0
8
17
4.76
2.93
1.0
1.4
—
—
—
0
0
8
17
4.76
2.93
1.0
1.4
—
—
—
0
0
22
102
2.20
2.90
1.3
1.4
—
—
—
0
0
49
302
1.68
2.82
3.6
2.4
1.2
1.2
mmol/l
0.13
43
255
15
59
2.58
2.80
1.3
1.6
—
—
—
0
0
70
473
1.55
2.78
2.2
1.7
—
—
—
0
0
23
111
2.12
2.76
1.8
1.2
—
—
—
0
0
12
42
2.90
2.76
1.3
1.4
—
—
—
0
0
514
4871
1.62
2.75
12.8
8.6
26.0
25.8
u/l
0.10
501
4686
130
995
1.40
2.74
1.2
1.3
0.7
2.0
u/ml
2.17
32
286
84
593
1.49
2.73
23.5
24.4
1.1
1.4
inr
1.33
13
84
8
19
4.26
2.68
9.4
2.7
3.9
3.5
nmol/l
—
8
19
532
5096
1.77
2.60
27.2
17.5
134.2
136.2
g/l
2.41
524
5014
30
166
1.85
2.50
1.7
2.2
—
—
—
0
0
8
22
3.67
2.37
4.3
1.3
14.9
15.8
ug/l
—
8
22
55
366
1.56
2.36
3.1
2.0
43.1
33.3
u/l
0.39
47
307
95
707
1.41
2.35
2.9
2.4
0.8
1.0
e6/l
0.78
60
403
56
376
1.54
2.31
4.6
2.8
250.8
243.1
u/l
0.19
51
349
227
1931
1.29
2.31
3.1
2.7
105.7
115.0
ug/l
0.42
205
1777
253
2183
1.29
2.30
4.8
3.4
0.0
0.0
estimate
0.00
50
364
205
1723
1.30
2.28
5.3
3.5
—
—
—
0
0
68
478
1.48
2.27
2.3
1.8
—
—
—
0
0
61
420
1.51
2.25
3.8
2.8
—
—
—
0
0
5
9
5.59
2.21
2.6
1.0
—
—
—
0
0
5
9
5.59
2.21
2.6
1.0
—
—
—
0
0
336
3018
1.28
2.17
3.7
3.0
56.9
45.6
u/l
0.68
308
2825
23
123
1.91
2.14
5.4
4.3
3.9
3.8
mmol/l
0.16
23
115
22
116
1.93
2.13
3.4
3.2
—
—
—
0
0
252
2193
1.27
2.08
6.6
4.8
0.0
0.0
estimate
0.00
50
363
254
2213
1.27
2.08
4.8
3.5
0.1
0.0
estimate
0.39
53
358
5
10
5.03
2.07
3.6
4.6
—
—
—
0
0
22
118
1.90
2.04
1.3
1.3
254.7
255.0
miu/ml
0.00
12
59
26
151
1.76
1.90
1.5
1.5
—
—
—
0
0
27
159
1.73
1.89
2.1
1.8
0.6
1.5
ug/l
1.38
27
145
40
262
1.57
1.87
3.8
3.8
1.7
2.0
mmol/l
0.29
31
197
16
79
2.06
1.87
1.4
1.3
—
—
—
0
0
16
79
2.06
1.87
1.4
1.3
—
—
—
0
0
8
28
2.88
1.87
1.3
1.2
2.0
2.1
mmol/l
—
8
28
29
176
1.68
1.83
1.3
1.2
0.2
0.9
u/ml
—
6
13
21
116
1.84
1.81
1.4
1.3
690.3
493.1
mg/l
0.36
21
107
12
54
2.25
1.75
1.1
1.2
2.5
7.9
u/ml
—
6
27
0
47
0.00
1.71
0.0
1.5
—
—
—
0
0
19
104
1.86
1.69
1.4
1.2
11.2
85.0
e6/l
0.76
14
87
38
253
1.54
1.68
1.8
1.5
—
—
—
0
0
85
659
1.34
1.66
3.0
2.6
2.9
2.4
e6/l
0.15
49
355
25
150
1.70
1.66
5.1
4.0
1.1
1.4
mmol/l
1.09
25
145
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
105
1.84
1.65
2.1
2.3
0.5
0.3
u/ml
—
9
60
85
663
1.33
1.60
1.5
1.4
—
—
—
0
0
8
33
2.44
1.54
1.0
1.1
—
—
—
0
0
14
73
1.94
1.45
1.3
1.4
—
—
—
0
0
6
22
2.75
1.44
18.3
11.7
0.6
0.7
mmol/l
—
6
22
9
39
2.33
1.43
1.0
1.1
—
—
—
0
0
104
853
1.27
1.36
1.9
1.7
1045.8
1186.8
nmol/l
0.90
74
645
13
68
1.93
1.34
1.2
1.4
—
—
—
0
0
67
520
1.33
1.32
1.6
1.8
1.5
1.5
%
0.16
59
458
155
1334
1.22
1.32
3.2
2.9
1031.3
1309.1
ng/l
0.51
128
1120
138
1176
1.23
1.29
2.7
2.3
330.3
5546.3
umol/l
3.80
123
1016
5
18
2.79
1.28
1.0
1.0
—
—
—
0
0
11
55
2.02
1.28
1.4
1.4
—
—
—
0
0
11
55
2.02
1.28
1.0
1.3
—
—
—
0
0
18
108
1.69
1.23
1.4
1.1
—
—
—
0
0
13
71
1.85
1.20
3.5
3.1
57.4
58.6
%
0.10
13
71
448
4279
1.23
1.18
16.3
10.5
81.3
79.9
ml/min/173m2
0.77
404
3444
211
1888
1.19
1.18
2.1
2.0
97.5
96.1
pmol/l
0.15
102
944
29
199
1.48
1.17
4.5
2.2
0.7
0.6
%
0.12
29
190
52
397
1.34
1.16
4.4
2.9
2.2
2.0
mmol/l
0.10
45
315
5
20
2.51
1.15
1.6
1.3
—
—
—
0
0
305
2820
1.18
1.15
2.9
2.9
—
—
—
0
0
100
835
1.24
1.13
1.2
1.3
42.8
35.6
iu/ml
0.15
29
273
17
104
1.65
1.10
2.1
2.8
1.7
1.5
mg/l
0.26
17
94
10
52
1.94
1.06
1.6
1.6
—
—
—
0
0
6
124
0.48
1.06
1.3
1.5
—
—
—
0
0
11
60
1.85
1.03
2.1
2.2
3.9
4.1
mmol/l
0.68
11
60
11
60
1.85
1.03
2.1
2.2
105.6
105.3
mmol/l
0.09
11
60
7
34
2.07
1.03
1.0
1.2
—
—
—
0
0
9
47
1.93
1.02
1.4
1.1
—
75.6
—
0
5
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
448
4301
1.20
1.00
6.3
6.0
39.1
40.0
mmol/mol
1.57
415
4010
105
894
1.21
1.00
4.2
3.8
210.0
345.6
ng/l
0.50
86
686
115
989
1.20
0.99
1.8
1.7
61364132.6
7046171.0
pmol/l
0.42
88
809
11
61
1.82
0.99
1.3
1.4
—
—
—
0
0
11
61
1.82
0.99
1.1
1.0
1.2
1.1
u/ml
—
6
25
15
92
1.65
0.98
3.3
4.0
7.8
8.1
kpa
0.22
15
84
12
69
1.76
0.97
1.2
1.2
—
—
—
0
0
10
54
1.87
0.97
1.0
1.1
—
—
—
0
0
12
71
1.71
0.89
3.0
2.8
4.0
4.3
e9/l
0.18
12
71
8
42
1.92
0.89
1.0
1.0
—
—
—
0
0
6
30
2.01
0.87
1.3
1.1
—
—
—
0
0
50
399
1.28
0.86
1.8
2.0
—
—
—
0
0
13
80
1.64
0.85
4.5
2.5
18.4
16.4
%
—
7
41
14
88
1.61
0.85
1.3
1.2
—
—
—
0
0
6
31
1.95
0.84
1.3
1.1
—
—
—
0
0
468
4532
1.19
0.83
5.2
4.5
5.9
6.0
mmol/l
0.05
424
4136
28
206
1.38
0.83
4.6
2.2
1.3
1.2
%
0.01
28
206
118
1036
1.18
0.82
5.3
3.7
1.0
1.0
kg/l
0.56
15
141
127
1122
1.17
0.81
1.6
1.5
19.7
21.4
nmol/l
0.65
112
967
6
33
1.83
0.79
5.2
2.1
—
—
—
0
0
6
33
1.83
0.79
1.0
1.1
—
117.5
—
0
8
16
107
1.51
0.77
1.3
1.2
4.5
3.9
mmol/l
0.91
16
99
9
54
1.68
0.75
1.0
1.1
—
—
—
0
0
5
24
2.09
0.74
1.0
1.3
—
—
—
0
0
146
1313
1.15
0.74
4.9
3.6
1.8
1.9
ug/l
0.29
124
1176
9
55
1.65
0.73
1.1
1.4
—
—
—
0
0
7
38
1.85
0.73
1.6
1.6
—
—
—
0
0
68
574
1.21
0.73
9.9
6.8
—
—
—
0
0
42
336
1.27
0.73
4.9
2.5
4.6
4.5
kpa
0.05
42
322
10
60
1.68
0.72
1.4
1.4
—
—
—
0
0
432
4174
1.15
0.71
18.8
12.7
39.8
40.2
%
0.42
291
2990
5
26
1.93
0.71
7.8
8.0
—
53.8
—
0
9
21
152
1.40
0.70
1.3
1.2
—
—
—
0
0
5
27
1.86
0.68
1.0
1.3
—
—
—
0
0
7
44
1.60
0.65
1.6
1.0
—
—
—
0
0
22
163
1.36
0.65
1.8
1.7
1.8
1.5
g/l
0.55
17
144
21
155
1.37
0.64
1.6
1.5
—
—
—
0
0
31
244
1.29
0.62
1.5
1.5
—
—
—
0
0
8
52
1.55
0.59
1.0
1.1
—
—
—
0
0
41
339
1.23
0.56
2.9
2.5
51.2
20.2
au/ml
—
5
13
8
126
0.63
0.55
1.3
1.1
—
11.6
—
0
12
11
74
1.50
0.53
3.1
1.7
—
—
—
0
0
20
152
1.33
0.52
1.3
1.2
—
—
—
0
0
6
40
1.51
0.51
1.5
1.8
—
—
—
0
0
87
777
1.14
0.51
1.6
1.5
—
—
—
0
0
42
354
1.20
0.49
1.9
1.9
—
—
—
0
0
7
45
1.56
0.49
1.6
1.0
—
—
—
0
0
7
45
1.56
0.49
1.6
1.0
—
—
—
0
0
7
46
1.53
0.48
1.6
1.0
—
—
—
0
0
7
46
1.53
0.48
1.6
1.0
—
—
—
0
0
7
46
1.53
0.48
1.6
1.0
—
—
—
0
0
16
120
1.34
0.46
1.1
1.1
—
—
—
0
0
89
802
1.13
0.46
1.3
1.2
13.8
9.6
u/ml
0.24
45
297
20
157
1.28
0.44
1.7
1.6
—
—
—
0
0
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
6
91
0.66
0.42
1.0
1.7
1.4
0.8
nmol/l
—
6
75
8
61
1.32
0.39
1.3
1.4
—
0.6
nmol/l
—
0
6
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
5
37
1.35
0.37
1.6
1.6
—
—
—
0
0
19
153
1.25
0.36
2.2
1.4
1.1
1.2
g/l
0.36
19
146
6
43
1.40
0.35
3.7
4.0
—
—
—
0
0
15
118
1.28
0.33
1.3
1.4
—
—
—
0
0
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
470
4629
1.09
0.31
4.8
4.5
4.6
4.7
mmol/l
1.00
437
4298
18
147
1.23
0.31
2.2
1.4
0.2
0.2
g/l
0.55
18
142
478
4712
1.09
0.30
5.4
5.0
2.7
2.8
mmol/l
0.49
442
4355
61
555
1.11
0.30
4.3
4.7
32.5
32.4
%
0.02
41
363
11
85
1.30
0.28
1.7
1.6
—
—
—
0
0
20
168
1.20
0.27
1.8
2.0
80.5
541.9
ug/l
1.05
20
154
5
71
0.70
0.26
1.4
1.3
—
—
—
0
0
5
72
0.69
0.26
1.2
1.6
—
—
—
0
0
451
4449
1.07
0.23
4.2
4.0
1.3
1.3
mmol/l
0.48
409
4080
466
4602
1.07
0.23
4.8
4.5
1.5
1.5
mmol/l
0.35
429
4252
5
42
1.19
0.21
1.0
1.2
1.9
1.5
nmol/l
—
5
37
0
10
0.00
0.21
0.0
1.6
—
1.3
—
0
10
15
126
1.20
0.21
1.5
1.3
—
—
—
0
0
8
105
0.76
0.21
1.0
1.3
—
—
—
0
0
5
43
1.16
0.21
4.8
2.0
12.8
13.2
%
—
5
43
17
198
0.85
0.21
2.8
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
5
70
0.71
0.17
2.6
1.8
—
—
—
0
0
108
1037
1.05
0.16
4.9
3.5
21.7
25.0
%
1.34
54
443
7
88
0.79
0.14
1.9
1.3
—
—
—
0
0
25
227
1.11
0.14
1.1
1.0
—
—
—
0
0
27
247
1.10
0.14
1.5
1.3
—
—
—
0
0
18
162
1.11
0.12
1.4
1.3
2.9
3.9
g/l
3.19
13
111
18
162
1.11
0.12
1.4
1.3
—
—
—
0
0
18
162
1.11
0.12
1.4
1.3
7.0
7.6
g/l
0.47
13
118
10
86
1.17
0.11
2.2
1.4
54.5
61.4
pmol/l
—
10
86
151
1478
1.03
0.09
3.3
3.1
6.6
7.5
mmol/l
1.82
130
1237
5
48
1.04
0.09
1.0
1.5
—
—
—
0
0
144
1469
0.97
0.08
4.4
3.9
15.4
8.5
mg/mmol
0.35
91
913
15
159
0.94
0.03
2.4
1.8
—
—
—
0
0
10
108
0.92
0.03
1.6
1.3
0.0
0.0
g/l
—
10
100
74
730
1.02
0.02
3.1
2.5
0.7
0.7
ug/l
0.11
46
472
41
419
0.98
0.02
1.7
1.8
—
—
—
0
0
10
106
0.94
0.01
1.6
1.3
0.0
0.0
g/l
—
10
99
12
114
1.05
0.00
2.4
2.0
3.6
4.8
iu/l
—
7
45
14
134
1.05
0.00
2.0
1.6
—
—
—
0
0
13
136
0.95
0.00
1.6
1.5
—
—
—
0
0
11
115
0.96
0.00
1.6
1.3
0.0
0.0
g/l
0.50
11
107
31
309
1.00
0.00
1.3
1.2
92.3
120.5
iu/ml
—
10
134
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
0.6
—
0
7
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_NOS_EXALLC – Benign neoplasm: Other/unspecified site
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).